Speaker illustration

Assistant Professor Peter Jirak

Salzburg university hospital, Salzburg (Austria)

Dexamethasone improves cardiovascular outcomes in critically ill COVID-19, a real world scenario multicenter analysis

Event: ESC Congress 2022

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Acute cardiac care and COVID

Thumbnail

Dexamethasone treatment attenuates pulmonary embolism rates in severe COVID-19 disease

Event: Heart Failure 2022

Topic: Clinical

Session: Focus on the right side

Thumbnail

C - reactive protein is a promising indicator of ventricular arrhythmias in pacemaker patients

Event: ESC Acute CardioVascular Care 2022

Topic: Clinical

Session: e-Posters session

Thumbnail

Higher incidence of stroke in severe COVID-19 is not associated with a higher burden of arrhythmias: Comparison to other types of severe pneumonia

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Arrhythmias e-posters

Thumbnail

Changes in micro-RNA secretion patterns following an anti-CD3 and ATG treatment regulate expression of adherens junctions in PBMCs

Event: Heart Failure 2021

Topic: Diabetes and the Heart

Session: ePoster session

Thumbnail

Analysis of novel cardiac markers sST2 and IL-33 in chronic heart failure with reduced ejection fraction

Event: ESC Congress 2019

Topic: Biomarkers

Session: Molecular mechanisms of cardiovascular inflammation

Thumbnail

Differences in the expression of the novel cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in HFpEF, ICM and DCM patients

Event: Heart Failure 2019

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail

A comparative analysis of novel biomarkers in sepsis and cardiovascular disease

Event: Acute Cardiovascular Care 2019

Topic: Biomarkers

Session: Moderated Poster 7: Acute Coronary Syndromes II

Thumbnail

A comparative analysis of the novel cardiac biomarkers sST2, GDF-15, Galectin-3, suPAR, H-FABP and Fetuin-A in heart failure, STEMI and NSTEMI patients

Event: ESC Congress 2018

Topic: Biomarkers

Session: Chronic heart failure – Diagnostic methods

Thumbnail

A comparative analysis of novel cardiac biomarkers (sST2, GDF-15, Galectin-3, suPAR, H-FABP and Fetuin-A) in patients with heart failure, STEMI and controls without cardiovascular disease

Event: Heart Failure 2018

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb